Skip to main content

Table 1 The association between lncRNA HOXA11-AS expression and clinicopathologic factors in NSCLC patients

From: Overexpression of lncRNA HOXA11-AS promotes cell epithelial–mesenchymal transition by repressing miR-200b in non-small cell lung cancer

Clinicopathologic factors

Patients number

LncRNA HOXA11-AS expression

P-value

Lower (n = 40)

Higher (38)

Sex

0.380

 Male

47

26

21

 

 Female

31

14

17

 

Age

0.621

 ≤60

45

22

23

 

 >60

33

18

15

 

Smoking index

0.718

 Yes

49

24

25

 

 No

29

16

13

 

Tumor size (cm)

0.500

 <3

40

22

18

 

 >3

38

18

20

 

Histological differentiation

0.233

 High and moderate

32

19

13

 

 Lower

46

21

25

 

Histology

0.816

 Squamous carcinoma

35

18

17

 

 Adenocarcinoma

33

16

17

 

 Other type

10

6

4

 

Lymph node metastasis

0.011**

 Negative

34

23

11

 

 Positive

44

17

27

 

TNM stage

0.007**

 I–II

43

28

15

 

 III

35

12

23

 
  1. TNM tumour-node-metastasis staging system
  2. ** P < 0.05